Gillian Jalimnson
Gillian Jalimnson is one of Hemp Gazette's staff writers and has been with us since we kicked off in 2015. Gillian sees massive potential for cannabis in areas of health, energy, building and personal care products and is intrigued by the potential for cannabidiol (CBD) as an alternative to conventional treatments. You can contact Gillian here.
Israel Proposes Significant Overhaul of Medical Cannabis Guidelines, Shifting Responsibility to Health Funds
Maine Issues Advisory After Medical Cannabis Found to Contain Unsafe Levels of Mold and Pesticides
Exploring the Potential of Smarter, Real-Time Clinical Trials in Drug Development
Cannabidiol Gel Trial for Fragile X Syndrome Fails Primary Endpoint Amid High Placebo Response
Clinics Prescribing Medicinal Cannabis for Anxiety and Depression Amidst Call for More Evidence
Review Highlights Investigational Pharmacological Treatments for Gambling Disorder
Medical Cannabis for ADHD: Examining the Limited Clinical Evidence and Patient Perceptions
Surgeon General Nominee Raises Cannabis Health Risks, Ackno…
Medicinal Cannabis for Autism: Emerging Evidence and Patien…
Cannabis Terpenes: Biological Sex & Tailored Medicinal Resp…

